A5071602233- Inflammatory Bowel Disease
- Microscopic Colitis
- Gastrointestinal Bleeding Diagnosis and Treatment
- Clostridium difficile and Clostridium perfringens research
- Healthcare Policy and Management
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Nosocomial Infections in ICU
- Primary Care and Health Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Pancreatitis Pathology and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Pediatric Hepatobiliary Diseases and Treatments
- Gastroesophageal reflux and treatments
- Adolescent and Pediatric Healthcare
- Healthcare cost, quality, practices
- Eosinophilic Esophagitis
- Helicobacter pylori-related gastroenterology studies
- Botulinum Toxin and Related Neurological Disorders
- Hospital Admissions and Outcomes
- Diabetes and associated disorders
Gold Coast Hospital
2018-2022
Logan Hospital
2021-2022
Queensland Health
2021
Biologic therapies are effective at inducing and maintaining remission in people with inflammatory bowel disease (IBD). Previous studies have associated TNF-a inhibitors weight gain, however, it is unclear if this a class-specific effect or manifestation of good control. To clarify issue, retrospective study was undertaken to examine changes over time during therapy different biologic agents.Adult patients IBD who received any biological for least 12 months, between 2008 2020, were...
Introduction: Cerebral edema is the leading cause of death in patients admitted with diabetic ketoacidosis. The osmolar gradient caused by high blood glucose results water shift from intracelluar fluid (ICF) to extracellular (ECF) space and contraction cell volume.There limited data regarding national incidence, predictors, outcomes cerebral among ketoacidosis (DKA). Methods: Data derived Nationwide Inpatient Sample (NIS) were analyzed for years 2002-2015. Adult Hospitalizations primary...
Biliary complications are the leading causes of morbidity and mortality after liver transplant (LT). However, national data on endoscopic retrograde cholangiopancreatography (ERCP) usage outcomes in LT patients lacking. Our study aims to identify trends, outcomes, predictors ERCP related this patient subgroup.We derived our cohort from Nationwide Inpatient Sample (NIS) Healthcare Cost Utilization Project (HCUP) between 2007 2017. were identified using ICD-9/10CM diagnosis codes who underwent...
Introduction: Cirrhosis is associated with worse outcomes in peptic ulcer bleeding (PUB). There are no population-based studies from the United States on impact of cirrhosis PUB outcomes. To investigate temporal trends and patients PUB. Methods: We analyzed Nationwide Inpatient Sample (NIS) Healthcare Cost Utilization Project (HCUP) data for years 2002-2014. Adult hospitalizations UGIB caused by ulceration were identified previously validated ICD-9-CM codes as primary diagnosis. was also...
Introduction: Previous studies have identified a weekend effect in outcomes of patients with various medical conditions including upper gastrointestinal hemorrhage (UGIH) suggesting worse for admissions. The aim our study was to analyze if so called ‘weekend effect' still exist rapidly improving health care delivery system UGIH hospitalizations. Methods: We analyzed Nationwide Inpatient Sample (NIS) and Healthcare Cost Utilization Project (HCUP) data years 2002-2014. Adult hospitalizations...
Abstract Background Biologic therapies are effective at inducing and maintaining remission in patients with inflammatory bowel disease (IBD). Previous studies have associated TNF-a inhibitors weight gain, however it is unclear if this a class-related effect or manifestation of clinical remission. We performed retrospective study to compare changes from baseline across different biological classes, examine patterns over time assess characteristics associations within each (sub)groups. Methods...